Volume 16, Number 4—April 2010
Porcine-Origin Gentamicin-Resistant Enterococcus faecalis in Humans, Denmark
Highlight and copy the desired format.
|EID||Larsen J, Schønheyder HC, Lester CH, Olsen SS, Porsbo LJ, Garcia-Migura L, et al. Porcine-Origin Gentamicin-Resistant Enterococcus faecalis in Humans, Denmark. Emerg Infect Dis. 2010;16(4):682-684. https://dx.doi.org/10.3201/eid1604.090500|
|AMA||Larsen J, Schønheyder HC, Lester CH, et al. Porcine-Origin Gentamicin-Resistant Enterococcus faecalis in Humans, Denmark. Emerging Infectious Diseases. 2010;16(4):682-684. doi:10.3201/eid1604.090500.|
|APA||Larsen, J., Schønheyder, H. C., Lester, C. H., Olsen, S. S., Porsbo, L. J., Garcia-Migura, L....Hammerum, A. M. (2010). Porcine-Origin Gentamicin-Resistant Enterococcus faecalis in Humans, Denmark. Emerging Infectious Diseases, 16(4), 682-684. https://dx.doi.org/10.3201/eid1604.090500.|
During 2001–2002, high-level gentamicin-resistant (HLGR) Enterococcus faecalis isolates were detected in 2 patients in Denmark who had infective endocarditis and in pigs and pork. Our results demonstrate that these isolates belong to the same clonal group, which suggests that pigs are a source of HLGR E. faecalis infection in humans.
Infective endocarditis is a life-threatening infection that involves the endocardial surface or vascular structures in proximity to the heart. Its intrinsic resistance to a number of antimicrobial drugs makes enterococcal infective endocarditis cumbersome to treat. For decades, the mainstay has been the combination of a cell wall–active agent (ampicillin, penicillin, or vancomycin) and gentamicin (1). However, high-level resistance to gentamicin hinders the bactericidal activity of combination therapy and increases the likelihood of clinical and microbiologic failure and even death (2).
High-level gentamicin-resistant (HLGR) Enterococcus faecalis has been associated with the hospital setting and prior healthcare exposure, which suggests the existence of a healthcare reservoir (3). Nevertheless, enterococci are gut commensals in humans and warm-blooded animals; therefore, reservoirs of HLGR E. faecalis conceivably might exist in the community not directly linked to the healthcare setting.
During 2000–2002, the proportion of HLGR E. faecalis isolates increased from 2% to 6% in the pig population in Denmark (4–6), which coincided with the emergence of HLGR E. faecalis isolates among patients with infective endocarditis in North Denmark Region. We undertook this study to determine whether pigs are a source of E. faecalis infections in humans.
Two HLGR E. faecalis isolates were collected by blood culture (BacT/Alert; bioMérieux, Marcy l’Etoile, France) from separate patients with infective endocarditis in North Denmark Region during 2001–2002 (Table). The regional clinical microbiology laboratory at Aalborg Hospital performed all original antimicrobial susceptibility testing by using Etest (bioMérieux) according to the manufacturer’s recommendations. We retrieved patient information recorded in a regional research database and used it to classify cases as definite, possible, or rejected according to the modified Duke criteria (8). A nosocomial origin of infection was determined in accordance with the US Centers for Disease Control and Prevention (9).
Patient A, an 81-year-old man with a previous stroke and a urinary catheter, was admitted twice within 1 month with HLGR E. faecalis bacteremia, a systolic murmur, transitory cerebral ischemia, and petecchial elements. Aortic valve endocarditis remained a clinical diagnosis because no echocardiography was performed (possible infective endocarditis). The patient died from a new stroke 1.5 months later.
Patient B, a 70-year-old woman with non–insulin-dependent diabetes mellitus, had recurrent bacteremia with HLGR E. faecalis and a diagnosis of aortic valve endocarditis confirmed by transesophageal echocardiography (definite infective endocarditis). Aortic valve replacement was performed, and she died 1.5 years later from an unrelated cause. Both cases of infective endocarditis were deemed to be community acquired.
During 2001–2002, a total of 20 HLGR isolates were collected from 19 pigs and from 1 sample of pork as part of the Danish Integrated Antimicrobial Resistance Monitoring and Research Program (DANMAP) (Table) (5,6). DANMAP also collected fecal samples from humans in the community during 2002–2006. The protocol was approved by the regional Scientific Ethics Committee before the investigation ([KF] 01-006/02). Two HLGR isolates were recovered from community-dwelling persons (Table): a 24-year-old woman (community healthcare worker) and a 2-year-old boy in whom inflammatory bowel disease had been diagnosed and who had received antiinflammatory therapy (mesalazine) within the preceding 30 days. Both regularly ate meat, including pork, and had no contact with food-producing animals during the 7 days before sampling.
MICs were determined for gentamicin (128–2,048 μg/mL) by using the Sensititre system (Trek Diagnostic Systems, East Grinstead, UK) according to current guidelines for inoculation and incubation recommended by the Clinical and Laboratory Standards Institute (10). MICs were consequently >1,024 μg/mL (Table).
Multilocus sequence typing (MLST) was performed for the 24 HLGR isolates as described (11). The 2 isolates from patients A and B, 18 of 19 isolates from pigs, the isolate from pork, and the 2 isolates from community-dwelling persons belonged to MLST type ST16 (Table). The remaining isolate from pigs belonged to MLST type ST35 (Table).
The major MLST type ST16 was further characterized by pulsed-field gel electrophoresis (PFGE) by using SmaI (12). The PFGE patterns were analyzed by using BioNumerics version 5.1 (Applied Maths, Kortrijk, Belgium), and isolates were grouped into PFGE clonal types by using Dice coefficients and a value of >82% relatedness (13). The PFGE patterns had a minimum of 86% relatedness and were clustered into 1 major clonal group.
The HLGR ST16 isolates were further screened by PCR for the aac(6′)Ie-aph(2′′)Ia gene, the aph(2′′)Ib and aph(2′′)Id genes and the aph(2′′)Ic gene to assess the genetic background of gentamicin resistance. All 24 HLGR ST16 isolates carried the aac(6′)Ie-aph(2′′)Ia gene and none of the other genes encoding gentamicin resistance.
Our study provides evidence of the existence of a widespread community reservoir of HLGR ST16 in pigs in Denmark during 2001–2002, which coincided with emergence of HLGR ST16 isolates among IE patients in North Denmark Region. One isolate was present in pork, which supports foodborne transmission, although direct transmission from animals to humans is also possible.
Our study has potential limitations. First, the method used by DANMAP (susceptibility testing of 1 colony per sample, rather than resistance prevalence per sample) may underestimate the extent of the HLGR reservoir in food-producing animals, meat products, and community-dwelling persons. Second, HLGR isolates from patients with infective endocarditis emanated from 2001 and 2002 and therefore do not represent recent trends.
Our findings support the results of a recent study in the United States that identified HLGR E. faecalis isolates with similar PFGE patterns (<3-band difference) from pork and fecal swabs of outpatients (14). These pig-related HLGR isolates, as well as our collection of HLGR ST16 isolates, carry the aac(6′)Ie-aph(2′′)Ia gene encoding gentamicin resistance.
Pig-related E. faecalis isolates belonging to ST16 carry pathogenicity island genes (7). These genes are more frequently detected among E. faecalis isolates recovered from blood or from fecal swabs of inpatients than among isolates from fecal swabs of healthy persons, which suggests that they are associated with invasiveness and virulence in humans (15).
With an annual production of >22 million slaughter pigs (4–6), Denmark has a large potential reservoir of HLGR ST16. Although HLGR ST16 was not detected in other food-producing animals and meat products, this type may not be exclusive to pigs. We found HLGR ST16 isolates in 2 community-dwelling persons during 2003–2005. Preference for eating pork, close contact with the healthcare setting, underlying disease, or a combination thereof may have predisposed these persons to become colonized by this potential pathogen.
HLGR ST16 appears to be transmitted from pigs to humans, although other routes of transmission also may exist. Further studies are needed to better understand the human and veterinary epidemiology of this zoonosis. Areas of study should include recent trends of HLGR among invasive E. faecalis; size of the reservoir in pigs; its association with antimicrobial drug use in pigs; and whether other animals, immunocompromised persons, or healthy persons constitute a community reservoir of HLGR ST16.
Dr Larsen is a postdoctoratal trainee in infectious diseases at the University of Copenhagen, Frederiksberg C. His research interests are the evolution of opportunistic pathogens and their epidemiology.
We thank Karin S. Pedersen for genotyping and PCR assays and Lena Mortensen for so meticulously handling the clinical isolates.
This work was supported by grant 271-06-0241 from the Danish Medical Research Council, the Danish Ministry of Family and Consumer Affairs, and the Danish Ministry of the Interior and Health as part of the Danish Integrated Antimicrobial Resistance and Research Program and the European Union Sixth Framework Program, Approaches to Control Multiresistant Enterococci: Studies on Molecular Ecology, Horizontal Gene Transfer, Fitness and Prevention, under contract LSHE-CT-2007-037410.
- Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.
- Aslangul E, Ruimy R, Chau F, Garry L, Andremont A, Fantin B. Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis. Antimicrob Agents Chemother. 2005;49:4144–8.
- Claesson C, Hallgren A, Nilsson M, Svensson E, Hanberger H, Nilsson LE. Susceptibility of staphylococci and enterococci to antimicrobial agents at different ward levels in four north European countries. Scand J Infect Dis. 2007;39:1002–12.
- Danish Integrated Antimicrobial Resistance Monitoring and Research Program. DANMAP 2000—consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark [cited 2009 Sep 1]. http://www.danmap.org/pdfFiles/Danmap_2000.pdf
- Danish Integrated Antimicrobial Resistance Monitoring and Research Program. DANMAP 2001—use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark [cited 2009 Sep 1]. http://www.danmap.org/pdfFiles/Danmap_2001.pdf
- Danish Integrated Antimicrobial Resistance Monitoring and Research Program. DANMAP 2002—use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark [cited 2009 Sep 1]. http://www.danmap.org/pdfFiles/Danmap_2002.pdf
- Shankar N, Baghdayan AS, Willems R, Hammerum AM, Jensen LB. Presence of pathogenicity island genes in Enterococcus faecalis isolates from pigs in Denmark. J Clin Microbiol. 2006;44:4200–3.
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Fifteenth Informational Supplement M100-S15. Wayne (PA): The Institute; 2005.
- Ruiz-Garbajosa P, Bonten MJ, Robinson DA, Top J, Nallapareddy SR, Torres C, Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol. 2006;44:2220–8.
- Turabelidze D, Kotetishvili M, Kreger A, Morris JG Jr, Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol. 2000;38:4242–5.
- Morrison D, Woodford N, Barrett SP, Sisson P, Cookson BD. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J Clin Microbiol. 1999;37:1084–91.
- Donabedian SM, Thal LA, Hershberger E, Perri MB, Chow JW, Bartlett P, Molecular characterization of gentamicin-resistant enterococci in the United States: evidence of spread from animals to humans through food. J Clin Microbiol. 2003;41:1109–13.
- Ruiz-Garbajosa P, Canton R, Pintado V, Coque TM, Willems R, Baquero F, Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect. 2006;12:1193–8.
- Table. Origins of gentamicin-resistant Enterococcus faecalis isolates and MICs for gentamicin, Denmark, 2001–2002
Please use the form below to submit correspondence to the authors or contact them at the following address:
Jesper Larsen, Department of Disease Biology, University of Copenhagen, Stigbøjlen 4, DK-1870 Frederiksberg C, Denmark
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 23, 2010
- Page last updated: December 23, 2010
- Page last reviewed: December 23, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)